Atea Pharmaceuticals (AVIR) Change in Account Payables (2020 - 2022)
Historic Change in Account Payables for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q4 2022 value amounting to $1.4 million.
- Atea Pharmaceuticals' Change in Account Payables rose 10811.62% to $1.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$2.0 million, marking a year-over-year decrease of 11927.3%. This contributed to the annual value of $206000.0 for FY2024, which is 8788.95% down from last year.
- As of Q4 2022, Atea Pharmaceuticals' Change in Account Payables stood at $1.4 million, which was up 10811.62% from -$12.8 million recorded in Q3 2022.
- In the past 5 years, Atea Pharmaceuticals' Change in Account Payables ranged from a high of $12.7 million in Q2 2021 and a low of -$17.7 million during Q4 2021
- Moreover, its 3-year median value for Change in Account Payables was $1.2 million (2020), whereas its average is $651500.0.
- Examining YoY changes over the last 5 years, Atea Pharmaceuticals' Change in Account Payables showed a top increase of 258800.0% in 2021 and a maximum decrease of 32269.57% in 2021.
- Over the past 3 years, Atea Pharmaceuticals' Change in Account Payables (Quarter) stood at -$4.2 million in 2020, then plummeted by 322.7% to -$17.7 million in 2021, then skyrocketed by 108.12% to $1.4 million in 2022.
- Its last three reported values are $1.4 million in Q4 2022, -$12.8 million for Q3 2022, and $10.2 million during Q2 2022.